Page last updated: 2024-08-25

tetrandrine and ER-Negative PR-Negative HER2-Negative Breast Cancer

tetrandrine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Law, BYK; Li, K; Li, W; Liu, T; Liu, X; Peng, J; Yang, J; Zhang, Z	1

Other Studies

1 other study(ies) available for tetrandrine and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Tetrandrine Inhibits Cancer Stem Cell Characteristics and Epithelial to Mesenchymal Transition in Triple-Negative Breast Cancer via SOD1/ROS Signaling Pathway. The American journal of Chinese medicine, 2023, Volume: 51, Issue:2 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase-1; Triple Negative Breast Neoplasms	2023

Article

Year

Tetrandrine Inhibits Cancer Stem Cell Characteristics and Epithelial to Mesenchymal Transition in Triple-Negative Breast Cancer via SOD1/ROS Signaling Pathway.

The American journal of Chinese medicine, 2023, Volume: 51, Issue:2

Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase-1; Triple Negative Breast Neoplasms

2023